From CTV News:
Health Canada is ordering a drug used for treatment of Parkinson's disease off the market.
The department has told maker Eli Lilly that sales of the drug Permax (pergolide mesylate) must cease as of Aug. 30. Studies have shown the drug can cause serious heart valve damage in some users.
Eli Lilly voluntarily withdrew the drug from the U.S. market in late March after studies in the New England Journal of Medicine underscored the valve problem risk.
Health Canada says there are alternatives to Permax available to people with Parkinson's disease. ..more
Monday, August 20, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment